Dec 2 (Reuters) - CSL Behring :
* findings of rapid open label extension study, conducted in patients with Alpha-1 Antitrypsin Deficiency
* findings show use of (A(1)-PI) therapy may slow progressive, irreversible loss of lung tissue, suggesting early intervention may be beneficial Source text for Eikon: ID:nPn8ChCZba Further company coverage: CSL.AX